Sentence examples for maintain clinical response from inspiring English sources

Infliximab has been demonstrated to induce and maintain clinical response and remission in patients with moderate-to-severe UC who have not responsed to conventional therapies [ 8- 12].

He et al. recently reported that the second fresh FMT was an effective and safe treatment to maintain clinical response in Crohn's disease three months after the first FMT (He et al., 2017a, b).

All patients who complete Study Period II and maintain clinical response are eligible to participate in Study Period III.

This is a conservative assumption, given that studies have shown that non-surgical treatment of SIJ pain has persistent yearly costs, presumably to maintain clinical response.

Although analyses evaluating participants who did not respond to treatment or who failed to maintain clinical response to treatment would be quite interesting and informative, it is beyond the scope of the current analysis.

Available studies suggest that CZP has the potential to achieve and maintain clinical response and remission in moderate to severe CD, and to improve quality of life compared with placebo.

Needless to say, it is particularly challenging for patients with disease refractory to several prior therapies – including biological agents, as was the case for the GO-AFTER study population [ 1, 2] – to achieve and maintain clinical responses.

This product is also used for inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn's disease with evidence of inflammation.

Is reducing the dose while maintaining clinical response associated with more radiographic joint damage in the long-term?

Golimumab treatment through 2 years was effective in maintaining clinical response (response rates: ACR20 63%–70%, DAS28-CRP 77%–86%, PASI75 56%722%) and inhibiting radiographic progression (mean change in PsA-modified SHS in golimumab-treated patients: −0.36), with no clear difference between doses.

Further, these patients maintained clinical responses and improvements in disease activity for up to 6 years, with no deaths or malignancies reported [ 17].